European Neuropsychopharmacology
Volume 20, Issue 12 , Pages 839-847 , December 2010

Chronic all-trans retinoic acid administration induced hyperactivity of HPA axis and behavioral changes in young rats

  • Li Cai

      Affiliations

    • Key Laboratory of Brain Function and Diseases, School of Life Science, University of Science and Technology of China, Chinese Academy of Sciences, Hefei 230027, Anhui, PR China
    • Department of Pathology, School of Basic Medicine, Anhui Medical University, Hefei 230032, Anhui, PR China
  • ,
  • Xue-Bo Yan

      Affiliations

    • Key Laboratory of Brain Function and Diseases, School of Life Science, University of Science and Technology of China, Chinese Academy of Sciences, Hefei 230027, Anhui, PR China
  • ,
  • Xiao-Ning Chen

      Affiliations

    • Key Laboratory of Brain Function and Diseases, School of Life Science, University of Science and Technology of China, Chinese Academy of Sciences, Hefei 230027, Anhui, PR China
  • ,
  • Qing-Yuan Meng

      Affiliations

    • Key Laboratory of Brain Function and Diseases, School of Life Science, University of Science and Technology of China, Chinese Academy of Sciences, Hefei 230027, Anhui, PR China
  • ,
  • Jiang-Ning Zhou

      Affiliations

    • Key Laboratory of Brain Function and Diseases, School of Life Science, University of Science and Technology of China, Chinese Academy of Sciences, Hefei 230027, Anhui, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 551 3607658; fax: +86 551 3600408.

Received 15 December 2009 ,Revised 14 June 2010 ,Accepted 24 June 2010.

References 

  1. Alexis NE, Dietrich WD, Green EJ, Prado R, Watson BD. Nonocclusive common carotid artery thrombosis in the rat results in reversible sensorimotor and cognitive behavioral deficits. Stroke. 1995;26:2338–2346
  2. Bao AM, Hestiantoro A, Van Someren EJ, Swaab DF, Zhou JN. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. Brain. 2005;128:1301–1313
  3. Bremner JD, Fani N, Ashraf A, Votaw JR, Brummer ME, Cummins T, et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Am. J. Psychiatry. 2005;162:983–991
  4. Cambier N, Menot ML, Schlageter MH, Balitrand N, Leblanc T, Bordigoni P, et al. All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia. Hematol. J. 2001;2:97–102
  5. Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20years on. Neurosci. Biobehav. Rev. 2005;29:1193–1205
  6. Chandraratna RA. Future trends: a new generation of retinoids. J. Am. Acad. Dermatol. 1998;39:S149–S152
  7. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005–1011
  8. Chen XN, Meng QY, Bao AM, Swaab DF, Wang GH, Zhou JN. The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders. Biol. Psychiatry. 2009;66:832–839
  9. Combs DJ, D'Alecy LG. Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1,3-butanediol. Stroke. 1987;18:503–511
  10. Crettaz M, Baron A, Siegenthaler G, Hunziker W. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochem. J. 1990;272:391–397
  11. de Oliveira MR, Silvestrin RB, Mello EST, Moreira JC. Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses. Neurotoxicology. 2007;28:1191–1199
  12. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982;217:855–857
  13. Ferguson SA, Cisneros FJ, Gough B, Hanig JP, Berry KJ. Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats. Toxicol. Sci. 2005;87:451–459
  14. Ferguson SA, Cisneros FJ, Hanig JP, Berry KJ. Oral treatment with ACCUTANE does not increase measures of anhedonia or depression in rats. Neurotoxicol. Teratol. 2007;29:642–651
  15. Fiorella PD, Giguere V, Napoli JL. Expression of cellular retinoic acid-binding protein (type II) in Escherichia coli. Characterization and comparison to cellular retinoic acid-binding protein (type I). J. Biol. Chem. 1993;268:21545–21552
  16. Geiger JM, Hommel L, Harms M, Saurat JH. Oral 13-cis retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings. J. Am. Acad. Dermatol. 1996;34:513–515
  17. Huang Q, Zhu H, Fischer DF, Zhou JN. An estrogenic effect of 5alpha-androstane-3beta, 17beta-diol on the behavioral response to stress and on CRH regulation. Neuropharmacology. 2008;54:1233–1238
  18. Hull PR, D'Arcy C. Acne, depression, and suicide. Dermatol. Clin. 2005;23:665–674
  19. Krezel W, Kastner P, Chambon P. Differential expression of retinoid receptors in the adult mouse central nervous system. Neuroscience. 1999;89:1291–1300
  20. Lane MA, Bailey SJ. Role of retinoid signalling in the adult brain. Prog. Neurobiol. 2005;75:275–293
  21. Le Douze F, Debruyne D, Albessard F, Barre L, Defer GL. Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of rat. Drug Metab. Dispos. 2000;28:205–208
  22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–408
  23. Luo T, Wagner E, Grun F, Drager UC. Retinoic acid signaling in the brain marks formation of optic projections, maturation of the dorsal telencephalon, and function of limbic sites. J. Comp. Neurol. 2004;470:297–316
  24. Maden M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 2007;8:755–765
  25. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E. Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur. J. Neurosci. 2003;18:457–472
  26. O'Reilly KC, Shumake J, Gonzalez-Lima F, Lane MA, Bailey SJ. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology. 2006;31:1919–1927
  27. O'Reilly K, Bailey SJ, Lane MA. Retinoid-mediated regulation of mood: possible cellular mechanisms. Exp. Biol. Med. 2008;233:251–258
  28. Owens MJ, Nemeroff CB. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991;43:425–473
  29. Paxinos G, Watson C. In: The Rat Brain in Stereotaxic Coordinates. Fourth Edition. Spiral Bound, New York: Academic Press; 1998;
  30. Ramos A, Mormede P. Stress and emotionality: a multidimensional and genetic approach. Neurosci. Biobehav. Rev. 1998;22:33–57
  31. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000;24:417–463
  32. Starling J, Koo J. Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. J. Drugs Dermatol. 2005;4:690–696
  33. Stokes PE, Sikes CR. Hypothalamic–pituitary–adrenal axis in psychiatric disorders. Annu. Rev. Med. 1991;42:519–531
  34. Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 2005;4:141–194
  35. Tafti M, Ghyselinck NB. Functional implication of the vitamin A signaling pathway in the brain. Arch. Neurol. 2007;64:1706–1711
  36. Trent S, Drew CJ, Mitchell PJ, Bailey SJ. Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in rats. Eur. Neuropsychopharmacol. 2009;19:876–886
  37. Wu LM, Han H, Wang QN, Hou HL, Tong H, Yan XB, et al. Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology. 2007;32:2500–2510
  38. Yan XB, Wang SS, Hou HL, Ji R, Zhou JN. Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav. Brain. Res. 2007;177:282–289
  39. Yasin SA, Costa A, Besser GM, Hucks D, Grossman A, Forsling ML. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology. 1993;132:1329–1336
  40. Zetterstrom RH, Lindqvist E, Mata de Urquiza A, Tomac A, Eriksson U, Perlmann T, et al. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur. J. Neurosci. 1999;11:407–416
  41. Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology. 2003;206:37–53

PII: S0924-977X(10)00146-X

doi: 10.1016/j.euroneuro.2010.06.019

European Neuropsychopharmacology
Volume 20, Issue 12 , Pages 839-847 , December 2010